Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada

about

Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada

Item

http://www.wikidata.org/entity/Q57817679

description

article

@en

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@en

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@nl

type

Item

label

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@en

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@nl

prefLabel

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@en

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@nl

P1476

Eosinophil counts in first COP ...... ost analysis in Quebec, Canada

@en

P2093

Alain Vanasse

http://www.w3.org/2001/XMLSchema#string

Josiane Courteau

http://www.w3.org/2001/XMLSchema#string

Maryse Bélanger

http://www.w3.org/2001/XMLSchema#string

Nathalie Carrier

http://www.w3.org/2001/XMLSchema#string

Pierre Larivée

http://www.w3.org/2001/XMLSchema#string

Simon Couillard

http://www.w3.org/2001/XMLSchema#string

Thomas G Poder

http://www.w3.org/2001/XMLSchema#string

P2860

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Pharmacoeconomic evaluation of COPD.

Direct costs of chronic obstructive pulmonary disease among managed care patients.

In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.

Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.

Exacerbations and associated healthcare cost in patients with COPD in general practice.

Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

P304

3065-3076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/COPD.S170747

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30349220

http://www.w3.org/2001/XMLSchema#string

P921

health policy

hospitalization

P932

6183549

http://www.w3.org/2001/XMLSchema#string